Skip to main content

Advertisement

SpringerLink
Log in

Novel medications inducing adrenal insufficiency

  • Comment
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

Emerging evidence demonstrates that an increasing number of novel medications have considerable potential to induce adrenal insufficiency. This condition might lead to acute adrenocortical insufficiency, which is potentially fatal; however, the condition could be avoided if clinicians are more aware of the new findings and their implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bornstein, S. R. Predisposing factors for adrenal insufficiency. N. Engl. J. Med. 360, 2328–2339 (2009).

    Article  CAS  Google Scholar 

  2. Bornstein, S. R. et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice guideline. J. Clin. Endocrinol. Metab 101, 364–389 (2016).

    Article  CAS  Google Scholar 

  3. Mebrahtu, T. F. et al. Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England. J. Clin. Endocrinol. Metab. https://doi.org/10.1210/jc.2019-00153 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ferraldeschi, R. et al. Molecular pathways: inhibiting steroid biosynthesis in prostate cancer. Clin. Cancer Res. 19, 3353–3359 (2013).

    Article  CAS  Google Scholar 

  5. Oksala, R. et al. SUN-LB002 CYP11A1 inhibition as a therapeutic approach for the treatment of castration resistant prostate cancer. J. Endocr. Soc. https://doi.org/10.1210/js.2019-SUN-LB002 (2019).

    Article  PubMed Central  Google Scholar 

  6. Hofmann, A. et al. Aldosterone synthase inhibition improves glucose tolerance in zucker diabetic fatty (ZDF) rats. Endocrinology 157, 3844–3855 (2016).

    Article  CAS  Google Scholar 

  7. Tan, M. H. et al. Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports. Clin. Diabetes Endocrinol. 5, 1 (2019).

    Article  Google Scholar 

  8. Gupta, S. Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders. Vasc. Health Risk Manag. 12, 421–433 (2016).

    Article  CAS  Google Scholar 

  9. Donegan, D. Opioid induced adrenal insufficiency: what is new? Curr. Opin. Endocrinol. Diabetes Obes. 26, 133–138 (2019).

    Article  CAS  Google Scholar 

  10. Harvey, P. W. Adrenocortical endocrine disruption. J. Steroid Biochem. Mol. Biol. 155, 199–206 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University Hospital Carl Gustav Carus, Dresden, Germany

    Stefan R. Bornstein & Cynthia L. Andoniadou

  2. Division of Endocrinology, Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK

    Stefan R. Bornstein

  3. Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany

    Tobias D. Bornstein

  4. Centre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King’s College London, London, UK

    Cynthia L. Andoniadou

Authors
  1. Stefan R. Bornstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tobias D. Bornstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cynthia L. Andoniadou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan R. Bornstein.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bornstein, S.R., Bornstein, T.D. & Andoniadou, C.L. Novel medications inducing adrenal insufficiency. Nat Rev Endocrinol 15, 561–562 (2019). https://doi.org/10.1038/s41574-019-0248-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-019-0248-9

  • Springer Nature Limited

This article is cited by

Search

Navigation